IDT Australia (ASX: IDT) is a Melbourne-based Contract Development and Manufacturing Organisation (CDMO) with more than 50 years of pharmaceutical manufacturing experience. Our cGMP capabilities span the production of active pharmaceutical ingredients (APIs) through to finished dosage forms (FDFs), including oral medicines (tablets, capsules, non-sterile liquids) and sterile injectables. We support projects from pre-clinical development through to commercial-scale supply.
We offer end-to-end services covering laboratory-based R&D, formulation, process optimisation, and GMP manufacturing, supported by in-house analytical and microbiology testing, project management, packaging, labelling, distribution, and regulatory expertise.
IDT Australia operates a 12,000m² cGMP modular facility in Boronia, Victoria, supporting active pharmaceutical and finished dose production from milligram-scale development through to commercial projects.
Our mission is to accelerate the journey from scientific discovery to life-changing therapies by delivering innovative, safe, and effective clinical product development solutions.
Our journey began over 50 years ago, driven by a vision to advance pharmaceutical manufacturing in Australia. Here are some of the key milestones that have shaped IDT into the CDMO we are today.
Our team is a blend of skilled professionals dedicated to innovation and quality.
Together, we turn ideas into impactful solutions.